Aquavit and Green Cross Sign Strategic Collaboration MOU on IBX-001 Product Development and Commercialization in Asia
8/9/2012 9:58:55 AM
More...
|
Green Cross Gains Market Approval With the World's 2nd Orphan Drug for Hunter Syndrome in South Korea
1/26/2012 9:42:03 AM
More...
|
Jennerex and Green Cross Announce Publication of Positive Clinical Data of JX-594 in Combination With Sorafenib in Advanced Liver Cancer
4/21/2011 7:54:56 AM
More...
|
Biocryst Pharmaceuticals (BCRX) Partner Green Cross Receives Marketing & Manufacturing Approval for Peramivir in South Korea
8/16/2010 8:00:29 AM
More...
|
Biocryst Pharmaceuticals (BCRX)'s Partner Green Cross Files for Peramivir Regulatory Approval in South Korea
1/8/2010 9:07:33 AM
More...
|
Abraxis BioScience, Inc. Announces Agreement with Green Cross for the Commercialization of ABRAXANE in Korea
11/28/2007 9:57:10 AM
More...
|
OctoPlus Grants Green Cross Exclusive Korean License To OP-145 For Chronic Middle Ear Infection
11/22/2006 10:53:16 AM
More...
|
Biocryst Pharmaceuticals (BCRX) And Green Cross Enter Agreement To Develop And Commercialize Peramivir In South Korea
6/14/2006 10:32:25 AM
More...
|
SanguiBioTech GmbH And Green Cross Plan To Evaluate Options For A Possible Cooperation
10/19/2005 5:12:57 PM
More...
|
Pall Corporation (PLL) Awarded Exclusive Contract From Green Cross For Leukoreduction Filters In Korea
10/19/2005 5:09:04 PM
More...
|